Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

Thomas ED . Bone marrow transplantation: a review. Semin Hematol 1999; 36: 95–103.

Horowitz M . Uses and growth of hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR (eds.). Thomas' Hematopoietic Cell Transplantation. Blackwell Scientific Publishers Inc.: London, New York, 2004, pp 9–15.

Craddock C . Haemopoietic stem-cell transplantation: recent progress and future promise. Lancet Oncol 2000; 1: 227–234.

Urbano-Ispizua A, Schmitz N, de Witte T et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002; 29: 639–646.

Gratwohl A, Baldomero H, Horisberger B et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374–2386.

Baron F, Storb R . Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Springer Semin Immunopathol 2004; 26: 71–94.

Bearman SI, Appelbaum FR, Back A et al. Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 1989; 7: 1288–1294.

Molina AJ, Storb R . In: Rowe JM, Lazarus HM, Carella AM (eds.). Hematopoetic Stem Cell Transplantation in Older Adults. Dunitz: London, 2000, pp 111–137.

Gratwohl A, Hermans J, Goldman JM et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998; 352: 1087–1092.

Leather HL, Wingard JR . Infections following hematopoietic stem cell transplantation. Infect Dis Clin North Am 2001; 15: 483–520.

Baron F, Storb R, Little MT . Hematopoietic cell transplantation: five decades of progress. Arch Med Res 2003; 34: 528–544.

Antoine C, Muller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003; 361: 553–560.

Locatelli F, Zecca M, Messina C et al. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 2002; 16: 2228–2237.

Frassoni F, Labopin M, Powles R et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393–1398.

Passweg JR, Socie G, Hinterberger W et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997; 90: 858–864.

Donnelly JP . Bacterial complications of transplantation: diagnosis and treatment. J Antimicrob Chemother 1995; 36 (Suppl. B): 59–72.

Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895–902.

Bostrom L, Ringden O . Viral infections. Major transplant related problems. In: Atkinson K (ed.). Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge University Press: Cambridge, 2000, pp 758–782.

Dadd G, McMinn P, Monterosso L . Protective isolation in hemopoietic stem cell transplants: a review of the literature and single institution experience. J Pediatr Oncol Nurs 2003; 20: 293–300.

Passweg JR, Rowlings PA, Atkinson KA et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1998; 21: 1231–1238.

Navari RM, Buckner CD, Clift RA et al. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. Am J Med 1984; 76: 564–572.

Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000; 6: 659–713.

Einsele H, Bertz H, Beyer J et al. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82 (Suppl 2): S175–S185.

Dykewicz CA . Hospital infection control in hematopoietic stem cell transplant recipients. Emerg Infect Dis 2001; 7: 263–267.

Slavin S . Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation. Lancet 2004; 364: 122–124.

Barrett J, Childs R . Non-myeloablative stem cell transplants. Br J Haematol 2000; 111: 6–17.

Bacigalupo A . Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant 2004; 33: 691–696.

Gratwohl A, Baldomero H, Passweg J et al. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey. Bone Marrow Transplant 2002; 30: 813–831.

McCann S, Byrne JL, Rovira M et al. Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 2004; 33: 519–529.

Birchard K . Irish bone marrow transplant unit closes. Lancet 2002; 356: 1012.

Orth B, Frei R, Itin PH et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996; 125: 799–806.

Clift R, Goldman J, Gratwohl A et al. Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. Bone Marrow Transplant 1989; 4: 445–448.

Fiocco M, Puuter H, van Houwelingen J . Reduced rank proportional hazards model for competing risks biostatistics. Biostatistics 2004; 1: 1–20.

Wingard JR, Vogelsang GB, Deeg HJ . Stem cell transplantation: supportive care and long-term complications. Hematology (Am Soc Hematol Educ Program) 2002, 422–444.

Junghanss C, Marr KA, Carter RA et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant 2002; 8: 512–520.

Hagen EA, Stern H, Porter D et al. High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation. Clin Infect Dis 2003; 36: 9–15.

Junghanss C, Boeckh M, Carter RA et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 2002; 99: 1978–1985.

Busca A, Locatelli F, Barbui A et al. Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2003; 5: 132–139.

Fukuda T, Boeckh M, Carter RA et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827–833.

Baron F, Baker JE, Storb R et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004; 104: 2254–2262.

Diaconescu R, Flowers CR, Storer B et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550–1558.

Junghanss C, Marr KA . Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture? Curr Opin Infect Dis 2002; 15: 347–353.

Storek J, Viganego F, Dawson MA et al. Factors affecting antibody levels after allogeneic hematopoietic cell transplantation. Blood 2003; 101: 3319–3324.

Storek J, Joseph A, Dawson MA et al. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 2002; 73: 1154–1158.

Kostova G, Heim D, Passweg J et al. Cytopenia and hematopoietic recovery after low intensity conditioning transplants. Croat Med J 2004; 45: 445–450.

Miano M, Manfredini L, Garaventa A et al. Home care for children following haematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 607–610.

Svahn BM, Remberger M, Myrback KE et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002; 100: 4317–4324.